Switzerland Moves to Strengthen Medicine Supply

The Swiss government has unveiled a series of measures aimed at improving the country’s medicine supply and reducing the impact of drug shortages. The proposals were announced on Friday as part of a public consultation process that will continue until October 16.

Under the proposed reforms, Switzerland plans to make it easier to import medicines when shortages are expected. Wholesalers and importers could receive temporary permission to bring in medicines that are not yet authorised in Switzerland, helping ensure patients continue to receive essential treatments.

The government also wants to expand the role of pharmacies during supply disruptions. Pharmacies may be allowed to manufacture certain medicines themselves when shortages occur, providing an additional safeguard for patients and healthcare providers.

Another major change involves online medicine sales. The proposed legislation would remove the general ban on mail-order sales of over-the-counter medicines. In the future, licensed chemists could sell and deliver non-prescription medicines online if authorised by their respective cantons.

Swiss authorities believe these measures will improve access to healthcare products while maintaining safety standards. Easier access to medicines could benefit patients, particularly those living in remote areas or facing difficulties visiting pharmacies in person.

The bill also introduces new rules for dispensing medicines. Pharmacies may be permitted to provide individual tablets instead of full packages in certain situations. This approach aims to reduce medicine waste and help combat the growing problem of antibiotic resistance.

In addition, chiropractors could gain the authority to prescribe medicines in a similar way to doctors. Supporters argue that this change would improve treatment efficiency and provide patients with more convenient access to healthcare services.

The consultation period will remain open until October 16, allowing healthcare professionals, industry representatives, and members of the public to provide feedback before the government finalises the legislation.